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Objectives. The purpose of this study was to determine whether
the type and extent of ventricular remodeling after infarction
influence inducibility of ventricular arrhythmias after infarction .
Background, Although serious ventricular arrhyffimlas after
infarction are related to ventricular dysfunction, the relation
between inducibility of ventricular ardiyMmias and ventricular
remodeling remains incompletely understood .
Methods. Rats that survived ligation of the left anterior de-
scending coronary artery (n = 218) were randomized to receive
placebo (saline solution) or captopril or propranolol therapy and
were followed up for 5 weeks . Hemodynamic and neurollumoral
blood measurements were obtained, and therapy was stopped .
Two days later, susceptibility to ventricular arrhythmias was
assessed by programmed electrical stimulation, and hearts were
prepared for pathologic studil :s, .
Results. Placebo-treated rats with a large myocardial infarc-
tion had ventricular dysfunction, marked neurobumoral activa-
tion, ventricular enlargement (endocardial circumference 16 ± 3
[mean ± SDI to 20 ± 4 mm, p < 0 .05) and increased cardiac
fibrosis (volume density of collagen 2 .3 ± 0.8% to 5.6 ± 2.4%,
In recent years, the importance of left ventricular remodel-
ing after infarction has been better appreciated (1,2). In
animal studies and in humans, pharmacologic interventions
that prevent scar expansion and ventricular dilation have
been shown to improve postinfarction survival (2-6) . Angio-
tensin-converting enzyme inhibitors are the best known
class of these drugs, but thrombolytic agents and nitrates
have also been found useful (2-6). Beta-adrenergic blocking
agents are another class of drugs found to be useful in
improving postinfarction survival, particularly in patients
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P < 0.05), In many rats this resulted in easily inducible ventric-
ular arrhyflunias (inducibility quotient 4.9 ± 2.2) . Captopril
attenuated the development of ventricular dysfunction, neurohu-
moral activation, ventricular hypertrophy and dilation (endocar-
dial circumference 18 ± 3 mm) and cardiac fibrosis (3 .1 ± 0 .8%,
p < 0.05) . These modifications were accompanied by decreased
inducibility of ventricular arrhythmias (inducibility quotient 1 .1
4
: 2.0, p < 0 .05) . Propranolol did not prevent ventricular
dysfunction, had variable effects on neurohumoral activation and
led to increased ventricular dilation (endocardial circumference
25 ± 4 nun, p < 0 .05) and cardiac fibrosis (7.7 ± 1 .2%, p < 0.05) .
Nevertheless, these morphologic changes led to decreased induc-
ibility of ventricular arrhythmias (inducibility quotient 2 .2 ±
2.5%,p<0.05) .
Conclusions . This study indicates that the inducibility of
ventricular arrhythmias can be reduced as a result of markedly
different effects on ventricular remodeling, indicating that the
relation between ventricular remodeling, arrhyffimias and sur-
vival is more complex than previously thought .
"J Am Coil Cardiol 1994,23.505-13)
with a large myocardial infarction (7) . Paradoxically, beta-
blockers modify ventricular remodeling in a fashion that is
very different from that of angiotensin-converting enzyme
inhibitors (3,8-10) . Beta-blockers lead to greater ventricular
dilation, whereas angiotensin-converting enzyme inhibitors
lead to less ventricular dilation (8-10) . Because the risk of
ventricular arrhythmias appears to increase with increasing
ventricular dysfunction, dilation and aneurysm formation
(11,12), and because postinfarction survival is inversely
proportional to ventricular volume (1,2), one may imagine
that the beneficial effects of beta-blockers on sudden death
and postinfarction survival are mostly the result of their
direct blocking of the effects of catecholamines on the
myocardium itself and occur despite deleterious effects on
ventricular remodeling. Alternatively, the relation between
ventricular remodeling and survival may be more complex
than currently thought and may be related not only to the
extent but to the type of remodeling involved . For example,
although beta-blockers and angiotensin-converting enzyme
inhibitors have very different effects on ventricular dilation,
0735-1097/94/$7
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both agents prevent the development of ventricular hyper-
trophy (8,9) and may thus both decrease susceptibility to
ventricular arrhythmias (13-15) .
In this study, we compared the effects of the beta-blocker
propranolol and the angiotensin-converting enzyme inhibitor
captopril with placebo treatment alone on postinfarction
ventricular remodeling and susceptibility to ventricular ar-
rhythmias, as assessed by programmed electrical Etimulation
in rats .
Methods
Experimental desip. A total of 368 male Wistar rats
(Charles River) weighing 200 to 225 g were chosen for the
study. During the baseline period, all rats had systolic
arterial pressure and heart rate measured three times while
awake and unsedated . These measurements were made over
a period of t week with a rat tail blood pressure cuff
(Harvard Apparatus) .
Myocardial infarction was induced in the 368 rats accord-
ing to methods previously described by Pfeffer et al . (16) .
Rats were anesthetized with ether . The heart was quickly
exteriorized through a left-sided thoracotomy, and the left
main coronary artery was ligated approximately 2 mm from
its origin . The heart was then replaced in its normal position
in the thorax, and the incision was closed with a Mikron
wound clip applicator (Clay Addams) after gently pressing the
chest to expel air from the cavity to avoid a pneumothorax .
Four hours after th.- operation, 150 rats had died . The
remaining 218 rats were randomly divided into three groups .
One group received an intraperitoneal injection of normal
saline solution and normal drinking water thereafter (saline
group, n = 77). A second group received intraperitoneal
captopril (10 mg/kg body weight) followed by 2 gutter in the
drinking water (3) (captopril group, n = 67) . A third group
received intraperitoneal propranolol (5 mg/kg) followed by
750 mg/liter in the drinking water (9) (propranolol group, n =
74). Intraperitoneal injections were done 4 h after infarction
so as not to significantly modify myocardial infarction size
(17).
Rats were then followed up and had their heart rate and
systolic arterial pressure measured as previously described 2
and 4 weeks after infarction . Thirty-four rats (44%) in the
saline group, 26 in the captopril group (39%) and 26 (35%) in
the propranolol group died during the 4-week follow-up
period. Four weeks after infarction, blood samples for
plasma norepinephrine, epic_#rine, renin activity and al-
dosterone measurements were obtained with rats under light
ether anesthesia . Briefly, the jugular vein was isolated and
cannulated with PE-50 intramedic polyethylene tubing
mounted on a truncated 23-gauge needle . Three milliters of
blood was then collected from which plasma was obtained
for neurohumoral measurements. Neurohumoral assays
were performed as previously described (18) .
During the same anesthesia and before samples were
drawn for neurohumoral measurements, a 2F Millar catheter
JACC Vol . 23, No. 2
February 1994 :505-13
with a pressure sensor at the tip was inserted into both the
jugular vein and carotid artery and advanced into the right
and the left ventricle, respectively, to measure intraventric-
ular pressures . All pressures were recorded on a Gould
2,600-s recorder . Catheters were then withdrawn and the
vessels ligated . The incision was closed by metal clips . An
additional 31 rats (13 in the saline, 7 in the captopril and I I
in the propranolol group) died during the recovery period
after the hemodynamic studies, leaving 30 (39%) rats in the
saline group, 34 (51%) in the captopril group and 37 (50%) in
the propranolol group for electrophysiologic and morpho-
logic studies. Only neurohumoral and hemodynamic results
in rats surviving until the electrophysiologic study were
considered .
Eledrophysiologic stimulation. Programmed electrical
stimulation protocol . The various drug regimens were then
continued until 48 h before the electrophysiologic stimula-
tion protocol (week 5), at which time administration of all
dru,gs was stopped to permit adequate washout (19,20) . The
surviving rats were anesthetized with intraperitoneal pento-
barbital (50 mgtkg) and artificially ventilated with humidified
room air supplemented with oxygen . Aiterial blood pressure
was recorded from the right carotid artery (P23 Db trans-
ducer, Gould), and heart rate was derived from that signal . A
lead 11 electrocardiogram (ECG) was recorded . Body tem-
perature was maintained at 37°C by lamps . Programmed
electrical stimulation was done through platinum electrodes
sewn on the epicardial surface of the right ventricular
outflow tract, and recordings were made at the left ventric-
ular apex. Pacing was performed by means of a Bloom
programmable stimulator . The protocol for programmed
electrical stimulation used in this study was similar to that
described by Cardinal et al . (21). The effective refractory
period was determined by premature stimulation with a
single extrastimulus after 20 paced beats at a basic cycle
length of 100 ms . Induction of ventricular arrhythmias was
then attempted by ventricular stimulation at a basic cycle
length of 100 ms (S I) with single, double and triple extra-
stimuli
(S2)
delivered after 20 paced beats (Fig . 1) .
The end point of programmed electrical stimulation was
induction of a ventricular tachyarrhythmia consisting of 2'
least 6 consecutive nondriven beats . A preparation was
considered noninducible when programmed electrical stim-
ulation produced either no ventricular premature beat or
only self-terminating salvos :55 beats. Distinction was rv .
made between ventricular tachycardia and ventricular fibril-
lation because in the rat heart transitions between wotricu-
lar tachycardia and ventricular fibrillation occu! spontane-
ously, and the latter can terminate spontaneously . A
ventricular tachyarrhythmia was considered nonsustained
when it lasted <_ l5 beats before spontaneous self-
termination, and it was considered sustained when it lasted
> 15 beats before terminating spontaneously or by overdrive
pacing. This 15-beat criterion allowed us to differentiate
between brief but significant responses and protracted ven-
JACC Vol . 23, No . 2
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Figure 1 . Tracings from a saline-treated rat with a large myocardial
infarction . Sustained ventricular tachycardia (>15 beats) (A) and
ventricular fibrillation (B) could be induced by I premature stimulus
(S2) after 20 paced stimuli (S,) . Either of these tachyarrhythmias
would have given this rat the maximal inducibility score of 6 . ECG
= lead 11 electrocardiogram, PS = programmed stimulation
.
tricular tachycardias against which overdrive pacing was
usually required
Arrhythmia scoring allowed the use of parametric statis-
tical tests to compare the various treatment groups with
respect to their susceptibility to develop programmed elec-
trical stimulation-induced ventricular tachyarrhythmias : 0 =
noninducible preparations, I = nonsustained ventricular
tachyarrhythmias induced with three extrastimuli, 2 = sus-
tained ventricular tachyarrhythmias induced with three
extrastimuli, 3 = nonsustained tachyarrhythmias induced
with two extrastimuli, 4 = sustained tachyarrhythmias in-
duced with two extrastimuli, 5 = nons stained tachyarrhyth-
mias induced with onee extrastimulus and 6 = sustained
tachyarrhythmias induced with one extrastimulus (Fig . 1) .
This scoring system reflects the fact that in long-term myo-
cardial infarction, specificity for detection of arrhythmogenic
substrates associated with spontaneous arrhythmias and sud-
den death is reduced, but sensitivity is increased as the number
of extrastimuli of the programmed electrical stimulation proto-
col increases from one to three (22) .
Burst-pacing protocol. At the end of the programmed
electrical stimulation protocol, the heart in all rats returned
to basal sinus rhythm and was subjected to burst pacing,
BELICHAPD ET AL .
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which consisted of drive trains of 200 stimuli of 2-ms rectan-
gular pulses applied to the heart, The basic cycle length was
set at 100 ms and was decreased using 5-ms decrements until
vent,-
:, alar arrhythmias were triggered
. For this portion of the
protocol, ventricular arrhythmias were classified as noninduc-
ible, nonsustained or sustained . Because there was no dif-
ference in triggered arrhythmias between rats with a moder-
ate or large infarction, for analyses these were consh Bred
together.
Morphologic studies . At the end of the programmed elec-
trical stimulation portion of the experiment, the hearts were
arrested in diastole with potassium chloride, removed and
rinsed in saline solution . After dissection of the atria and
great vessels, heart weight and left ventricular weight were
rapidly determined (AE163 balance, Mettler) . Thereafter,
the left ventricle of the heart was filled with saline solution to
a pressure of 15 nim Hg, sealed and fixed in formalin for 24 h
.
Two cross sections of the heart were obtained at 1-mm
intervals midway between the base and the apex of the heart .
Infarct size was determined from the tissues obtained
from the two cross sections. These tissues were dehydrated
and embedded in paraffin, and 5-,um sections were cut . A
representative section from the two cross sections of each
heart was stained with Masson trichrome (from which he-
matoxylin was omitted) and mounted on a slide for projec-
tion to a magnification x 12. Slides were examined with an
automatic image analysis processor (NS 1500, Nachet) under
a monozoom microscope . The length of sear and that of
noninfarcted muscle for both the endocardial and epicardial
surfaces were numerically summed separately, as were the
endocardial and epicardial circumferences obtained by
planimetry
. The ratio of the sum of the length of scar and
surface circumference defined the infarct size for each of the
myocardial surfaces . Final infarct size was expressed in
percent as the average of the infarct size of the endocardial
and epicardial surfaces times 100 . For both cross-sectional
levels, minimal scar thickness was measured, and dilation
index (left ventricular cavity area/left ventricular area) was
calculated . The final value for each heart was the value
obtained at each cross-sectional area divided by 2 . A large
myocardial infarction was defined as involving }45% of left
ventricular circumference, a moderate infarction as involv-
ing ?20% but <45% and small or sham myocardial infarction
as involving <20% .
To assess the extent of the myocardial collagen network,
samples from both of the tissue cuts obtained were stained
with Sirius red as a 0 .1% solution in saturated aqueous picric
acid. The Sirius red staining technique has a good affinity for
collagen fibers and gives pictures of high contrast, as de-
scribed previously by Junqueira et al . (23) . This contrast was
increased by using a 545-nm interference filter . Each slide
was examined under the microscope (x25 magnification)
with the same automatic image analysis processor previ-
ously described, and, based on morphologic mathematic
principles, an algorithm was developed to analyze the colla-
gen matrix of the heart (24)
. This algorithm measures the
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Table 1
. Hernodynarnic Variables 4 Weeks Postinfarction During Therapy
*p < 0.05 versus saline s
olution . t p < 0.05 propranolol versus captopril . t p < 0 .05 versus sham or small infarction
. Values presented are mean value ± SD .
Electrophysiologic studies were done 2 days after stopping
medications . LV = left ventricular; MI = myocardial infarction
; RV = right ventricular .
relative area occupied by collagen in each field . T"irty-five
fields were analyzed in the subendocardial lay ._ and 35
others in the subepicardial layer in the noninfarcted part of
the wall of each left ventricle. The infarcted area, which was
completely scarred I month after the coronary ligation, and
the fibrosis-rich border zone were not included in this
measurement. Thus, analysis of fibrosis was performed only
in viable tissue that was not involved with the coronary
artery ligation
Sladstical methods. Values are expressed as mean value
1 SD, except in Figure 2, where they are expressed as
mean value ± SE. Rats were classified according to myo-
cardial infarction size (large, moderate and small or sham) .
To compare the values from these groups, a nested model
of analysis of variance was performed where infarction size
was nested within treatment groups . When the overall dif-
ference between the treatment or myocardial infarction size
groups was significant, a one-way analysis of variance fol-
lowed by a Student-Newman-Kouls test was performed .
Electrophysiologic data (scoring of programmed electrical
stimulation-induced arrhythmias) were compared by a
Kruskal-Wallis test followed by a Mann-Whitney test . Ven-
tricular arrhythmias during the burst-pacing protocol were
compared by a Fisher exact test (two-tailed) . A p value <
0.05 was considered significant .
Results
Anodlynamle sbAles . Baseline systolic arterial pressure
and heart rate measurements performed before operation
were similar in all groups . Systolic arterial pressure and
heart rate during the treatment period varied according to
myocardial infarction size and therapy assignment (Table 1) .
Saline-treated rats with a medium or large myocardial infarc-
JACC Vol . 23, No. 2
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Lion had a decrease in systemic systolic arterial pressure but
no change in heart rate . Left and right ventricular end-
diastolic pressures also increased, as did right ventricular
systolic pressure. These changes were less marked in saline-
treated rats with a moderate infarction .
Compared with the use of saline solution, the use of
captopril resulted in a decrease in systemic systolic arterial
pressure in all groups regardless of infarction size (Table 1) .
In addition, the use of captopril prevented the development
of all hemodynamic differences between sham or small,
moderate and large myocardial infarction groups. Under
heavier barbiturate anesthesia at the time of electrophysio-
logic testing, 2 days after captopril therapy was stopped, no
difference in heart rate or systemic systolic arterial pressure
was noted between the captopril and saline groups .
Four weeks after infarction, the use of propranolol,
compared with the use of saline solution, decreased heart
rate and either decreased or tended to decrease systemic
systolic arterial pressure in all groups (Table 1) . However,
except for an increase in left ventricular end-diastolic pres-
sure in rats with a small myocardial infarction, the use of
propranolol did not modify the changes in left ventricular
end-diastolic or right ventricular pressures seen with in-
creasing infarction size in saline-treated rats . Compared with
captopril, propranolol decreased heart rate in all groups .
Under heavier barbiturate anesthesia at the time of electro-
physiologic testing, 2 days after propranolol administration
was stopped, no difference in heart rate or systemic systolic
arterial pressure was noted between the propranolol and
saline groups .
Neurobumoral levels . In saline-treated rats, neurohu-
moral activation, as reflected by circulating neurohormones,
increased progre-sively along with increasing infarct size
(Table 2). Except for causing t significant increase in plasma
Awake Light Anesthesia VAT Ether
Electrophysiologic Study
(no medications,
barbiturate anesthesia)
Systemic Systolic LV Systolic LV End-Diastolic RV Systolic RV End-Diastolic Systemic Systolic
Arterial Pressure
(mm Hg)
Heart Rate Arterial Pressure Pitssure Pressure Pressure Pressure
(beats/min) (mm Hg) (mm Hg) (mm Hg) (mm Hg) (mm Hg)
Heart Rate
(beats/min)
Sham or small MI
Saline solution (n = 11) 389 ± " 153 :t 16
128 ± 19 8 ± 4 33 ± 4 2 ± 3 402 ± 34 134 ± 12
captopril (n = 10) 393 ± 59
117 ± 14* 106 ± 12* 10 ± 5 33 ± 3 3 ± 3 402 ± 51 137 ± 14
Propranolol (a = 13) 299 2: 25*t 139 ± 24t 131 ± 22t
13 ± 411 f 32 ± 3 3 ± 3 389 ± 35 139 ± 24
Moderate MI
Saline solution (n - 8) 401 ± 50
137 ± 9t 135 ± 11 12 ± 4 34 ± 3 4 ± 2 421 ± 51 131 ± 14
captopril (n - 12) 404 ± 66
109 ± 14* 101 ± 9* 11 ± 8 38 ± 10 2 ± 4
400 ± 57 129 ± 11
Propranolol (n = 12) 326 ± 31*t 133 ± 13t 124 ± 11*t
13 ± 6 39 ± 10 6 ± 4 400 ± 29 133 ± 9
Lale Ml
Saw solution (n - 11) 400 ± 48 131 ± 18t
120 ± 15 22 ± 9t 48 ± lot 5 ± 2t 434 ± 41 121 ± 19
Captopril (n - 12) 394 t 41
113 ± 13* 99 ± 101, 10 ± 6* 32 ± 7* 3 ± 3 411 ± 31 123 t 16
Propranotol (n - 12) 356 ± 41*tt 116 2 18*t 101 ± 11*t 21 ± 7t ,+
54 ± 104 5 ± 3 427 ± 38 126 ± 1r,
JACC Vol. 23, No . 2
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Table 2. Neurohumoral Values 4 Weeks Postinfarction During Therapy
renin activity, the use of captopril had very little effect in rats
with a sham, small or moderate myocardial infarction .
However, in rats with a large infarction, compared with
saline-treated rats, the use of captopril resulted in a signifi-
cant decrease in plasma norepinephrine and epinephrine as
well as a tendency toward a decrease in aldosterone . Except
fcr an insignificant decrease in plasma renin activity, the use
of propranolol also had little effect in rats with a small
infarction . In rats with a moderate infarction, the use of
propranolol resulted in an increase in plasma aldosterone .
This was accompanied by an insignificant decrease in plasma
renin activity and plasma norepinephrine . In rats with a large
myocardial infarction, the use of propranolol, compared
with the use of saline solution, resulted in a significant
decrease in plasma norepinephrine and epinephrine, an
increase in plasma aldosterone and an insignificant decrease
in plasma renin activity. Compared with captopril-treated
rats, propranolol-treated rats with a large myocardial infarc-
tion had significantly lower plasma renin activity but a
significantly higher plasma aldosterone level .
Electrophysiologic stimulation . Arrhythmia scores in
sham-operated rats and rats with a small myocardial infarc-
tion were very low (< 1) in all three treatment groups (Fig . 2) .
In contrast, ventricular tachyarrhythmias consisting of ven-
tricular tachycardia (regular electrocardiographic [ECG]
morphology and rate) and ventricular fibrillation (unstable
ECG morphology and rate) were inducible by programmed
stimulation in saline-treated rats with a moderate or large
myocardial infarction (Fig . 1). Accordingly, arrhythmia
scores were high (>4) in saline-treated rats with a moderate
or large myocardial infarction (Fig. 2). Both captopril and
propranolol treatment decreased the inducibility of ventric-
ular tachyarrhythmias, and there was a significant reduction
in arrhythmia scores in these groups compared with scores
in the saline-treated group .
In sham-operated rats or rats with a small infarction, no
sustained ventricular arrhythmias could be induced by burst
pacing, and insignificant differences were found in the induc-
ALICHARD ET AL .
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*p < 0 .05 versus saline s olution
. t p < 0
.05 propranolol versus cqwK± fp < 0 .05 versus sham or small infarction . Values presented are mean value ± SD .
MI = myocardial infarction .
ibility of nonsustained ventricular arrhythmias according to
treatment groups (37% in the saline group, 40% in the
captopril group and 10% in the propranolol group) . How-
ever, sustained ventricular arrhythmias could be induced in
rats with a moderate or large myocardial infarction (Table 3),
and significant differences were noted between groups, with
propranolol and captopril causing a significant decrease in
sustained ventricular arrhythmia induction .
Morphologic studies . In the saline-treated rats, the heart
weight/body weight ratio was greater in rats with a moderate
or large myocardial infarction (Table 4) . With increasing
myocardial infarction size, left ventricular endocardial cir-
cumference and dilation index (left ventricular cavity area/
left ventricular area) increased progressively, as did cardiac
fibrosis, as assessed by volume density of collagen (Table 4,
Fig. 3) . However, minimal scar thickness did not .
In captopril-treated rats, the heart weight/body weight
ratio was lower than that in saline-treated rats, only in those
with a large infarction (Table 4) . In contrast to findings in
saline-treated rats, left ventricular endocardial circumfer-
ence and cardiac fibrosis did not increase significantly with
increasing infarction size (Table 4, Fig. 3). Captopril also
prevented a decrease in minimal scar thickness but was
unable to completely prevent the increase in dilation index in
rats with a large myocardial infarction .
All three groups of propranolol-treated rats had a similar
heart weight/body weight ratio (Table 4)
. In propranolol-
treated rats, left ventricular endocardial circumference, di-
lation index and cardiac fibrosis increased, and minimal scar
thickness decreased progressively with increasing infarct
size . These changes reached statistical significance in rats
with a large infarction (Table 4, Fig . 3). Compared with
saline-treated rats, propranolol-treated rats with a large
myocardial infarction had an increase in endocardial circum-
ference, dilation index and myocardial fibrosis but no change
in minimal scar thickness
. Compared with captopril-treated
rats, propranolol-treated rats with a moderate infarction had
an increase in dilation index and cardiac fibrosis and a
Sham or small MI
Saline solution (n
= 11)
344
129 302 ± 256 25 t 17
22 ± 4
Captopril (n = 10) 357 110 279
± 103 122 ± 37* 33 ± 11
Propranolol (n = 10) 302 67 295 ± 64 11 ± 4t
29 ± 10
Moderate MI
Saline solution (n = 8) 5% ± 216 476 ± 419
32±17 30±7
captopri! ('I
= 12)
494 ± 191 486 ± 292 137 ± 56*
23±7
Propranolol (n = 12) 398 ± 259 439 ± 246 15 * 101
47 ± 21*
Large MI
Saline solution (n = 11)
824
± 4M*
930
± 80 40±A 38 ± 19t
Captopril (n = 12) 532 ± 21c* 436 ± 318* 120 ± 64*
29 ± 13
Propranolol (n = 12)
585 ± 229** 321 ± 163* 22 ± 94 58 ± IQ
Norepinephrine Epinephrine Plasma Benin Activity
AldosLerone
(gymb (pg/ml)
(ng/mlifh)
NO
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LARGE INFARCT ION
1
a
2. Inducibility of ventricular tachycardia or fibrillation by
programmed electrical stimulation (inducibility quotient) . For de-
tails of scoring, see Methods . Values are mean value ± SE . Tip <
0.05 versus sham or small infarction . *p < 0 .05 versus saline
solution . Small or sham infarction : saline solution (n = 11). captopril
(n = 10), propranolol (n = 10) . Moderate infarction : saline solution
(n = 8), captopril (n = 12), propranolol (n = 12) . Large infarction :
saline solution (n = 11), captopril (n
a
12), pi, nranolol (n = 12) .
decrease in minima' scar thickness. Those with a large
infarction had an increase in left ventricular endocardial
circumference, dilation index and cardiac fibrosis and a
decrease in minimal scar thickness .
Discussion
This study indicates that increased susceptibility to the
induction of ventricular arrhythmias by programmed electri-
T
3. Ventricular Arrhythmias With Burst Pacing in Rats With
a Moderate or
a Myocardial Infarction
*p < 0
.05 versus saline solution. VF = ventricular fibrillation
; VT =
ventricular tachycardia
.
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cal stimulation accompanies left ventricular remodeling after
infarction in rats with a moderate and large myocardial
infarction. Both propranolol and captopril led to a decrease
in susceptibility to the induction of ventricular arrhythmias
by programmed electrical stimulation despite having mark-
edly different effects on ventricular remodeling . Whereas
captopril therapy prevents ventricular dilation, scar thin-
ning, cardiac fibrosis and a disproportionate increase in left
ventricular cavity/mass ratio (dilation index), propranolol
therapy causes greater ventricular enlargement, scar thin-
ning, cardiac fibrosis and an increase in the dilation index .
Thus, drug-induced changes in postinfarction left ventricular
remodeling can take many forms, some of which seem
paradoxic in their ability to decrease the inducibility of
ventricular arrhythmias and prolong survival. Previously
underestimated or unsuspected factors may be involved in
forging the relation between ventricular remodeling, induc-
tion of ventricular arrhythmias and survival, and more work
is required to identify and understand them. Two potential
mechanisms identified in this study are the development of
ventricular hypertrophy and the degree of homogeneity in
cardiac fibrosis between the peri-infarction region and the
rest of the heart .
In this study, many of the previously described hemody-
namic, neurohumoral and ventricular remodeling changes
described in rats 5 weeks after myocardial infarction were
documented in the saline-treated group (3,8,9,14,25-28) .
With increasing myocardial infarction size, systemic arterial
pressure decreased, whereas left and right ventricular end-
diastolic and right ventricular systolic pressures increased,
indicating some evidence of biventricular dysfunction . This
was accompanied by progressively greater activation of all
measured neurohormones, an increase not dissimilar to that
previously described by others in this model (8,27,28) .
However, in this study, neurohumoral activation was more
generalized, with an increase in aldosterone being described
for the first time . Previously documented changes in ventric-
ular remodeling were also found (3,8,9,25,26,29) . Rats with
the largest myocardial infarctions had an increase in heart
weight/body weight ratio, probably caused in part by right
ventricular hypertrophy (29). This was accompanied by
marked left ventricular dilation and a disproportionate in-
crease in left ventricular cavity/mass ratio (dilation index) .
An increase in fibrosis of the remaining viable portion of the
heart was also found (8), possibly the result of an increase in
aldosterone levels (30) .
Not surprisingly, these changes were accompanied by an
increased susceptibility to induction of ventricular tachyar-
rhythmias by programmed electrical stimulation or burst
pacing. Although the most likely site of these inducible
ventricular arrhythmias was the peri-infarction border zone
(31), it is also possible that the development of myocardial
hypertrophy and cardiac fibrosis played a role . Action
potential duration is known to be prolonged in this model
(14), and an increase in susceptibility to inducible ventricular
arrhythmias is known to occur with ventricular hypertrophy
Arrhythmia Saline Solution Captopril Propranolol
Noninducible 1/19 (5%) 12124 (50%0)* 9124 (38%)*
Nonsustained VT or VF 3/19(16%) 9124 (38%) 9124 (38%)
Sustained VT or VF 15/19 (79%) 3124 (12%)* 6/24 (24%)*
3
S or SMALL
INFARCTION
® SALINE
2 •
CAPTOPRIL
PROPRANOLOL
I .
0
6
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Table 4. Morphologic Characteristics of the Hearts at Time of Induced Mitt
collagen
*P < 0 .05 versus saline s olution . t p < 0 .05 versus sham or small myocardial infarction, tp < 0 .05 propranolol versus captopril . Values presented are mean
value SD. Rats are classified
as
to whether (hey had it sham or small, moderate or large myocardial infarction . Body weight is at time of induced death
. Dilation
index
	
left ventricular cavity area/left ventricular area .
in the spontaneously hypertensive (SHR) rat (14,15) . Of situation remains uncertain, and further studies are required
note, this increased susceptibility of the SHR rat has been before the full significance of these findings are understood .
correlated with both the degree of hypertrophy and cardiac In favor of some type of relation is the finding that arrhyth-
fibrosis (15) . How the increased inducibility of ventricular mias were inducible exclusively in rats with a moderate to
arrhythmias in this model relates to the human postinfarction large infarction and not in sham-operated rats .
Figure 3 . Representative midventricular
cross sections from sham-operated rats
(A) and rats with a myocardial infarction
(MI) treated with saline solution (B), captopril
(C) and propranolol (D), illustrating the in-
crease in ventricular dimension and the de-
crease in wall and scar thickness in propranolol-
treated hearts and the preserved ventricular
dimensions and increased scar thickness in
captopril-treated hearts .
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LARGE MI
SqLINE
LARGE M! PROPRANCLCL.
Sham or Small Infarction
Moderate infarction
Large Infarction
Saline
Saline
Saline
Solution
0 = In
captopril
In = 10)
Propranolol
In = IM
Solution
in - 8)
caploplil
(n -
12)
Propranolol
In = 12)
Solution
Captopril
W -
12)
Propranolol
(n = 12)
W = 10
Body weight (g) 399 ± 23 362 = 28' 361 20' 370 = 19t
351 t 28 342 t 20 346 t 20t 349 t 19
348 t 20
Heart weightibody 2 .8 a 0 .3 2
.7 a 0 .2 2 .9 0 .2 3.4 ± Ut 3 .0 a 0.4 3 .2 ± 0.5
3 .8 ± 0.7t 3 .0 t 0 .3' 3
.3 ± 0 .8
weight
(MA)
Myocardial infarction
30 ± 5 28 t 6 32 t 10
49 t 10 58 ± 7
-
53 :L 13
07c circumference)
Infarct length (mm)
-
7.6 ± 0 .8 7.2 ± 1 .1
9 .7 ± 1 .6 11 .2 ± 1
.3
8 .1 ± 1 .2
10.0 1 .7
Minimal scar thickness
-
0.23 t 0 .11 0
.29 ± 0.09t 018 ± 0.05 0.19 0 .03
0 .30 t 0.14* 0 .15 ± 0 .03+,
(mm)
Endocardial 5 ± 3 17
3 17 ± 2 0 ± 3 20 ± 4 20 4t 18 t 3
5 ± 4"t
86 ± 3
circumference (411m)
Dilation index 0 .46 1 0 .08 0 .51 t 0 .04 0.E 0 .08 O.58 t 0.09t
0
.55 t 0.05
0
.75 "*t
0.67 ± 0
.405
0
.E ± 0A81 0 .91 ± 0 .O9*tf
Volume density of 0.023 i 0 .08 OA26 i 0 .013 1103! %005 OM3 ± 0 .013 0 .026 n 0.007 0 .O49
0.O1441 0.06 ± OA241 0 .031 ± 0,008" 0
.07 ± OA24f
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The modifications in hemodynamic, neurohumoral and
ventricular remodeling characteristics caused by captopril in
this study are consistent with those previously described for
angiotensin-converting enzyme inhibitors by others
(3,8,14,27-29) . Captopril decreased systemic systolic arterial
pressure in all groups and prevented the increase in left and
right ventricular filling pressures and right ventricular sys-
tolic pressures. This evidence of preserved left and right
ventricular function was accompanied by an attenuation of
neurohumoral activation and significant modifications in left
ventricular remodeling . Captopril prevented an increase in
heart weighWbody weight ratio, ventricular dilation, scar
thinning and fibrosis of the remaining viable myocardium .
The exact mechanism by which captopril therapy reduced
arrhythmia inducibility in rats with a moderate or large
infarction remains speculative and may be multifactorial .
Because survival is related to ventricular dilation in both this
model (3) and in humans (1,2), part of the protective effect of
captopril may have been the result of its effects on preserv-
ing ventricular shape and preventing ventricular dilation
(3,4). A second beneficial effect of captopril may have been
the result of its attenuating effect on the development of
myocardial hypertrophy and cardiac fibrosis, which may
cause slow and inhomogeneous activation, leading to reentry
(32). As previously discussed, there is evidence to suggest
that myocardial hypertrophy and cardiac fibrosis predispose
to the development of ventricular arrhythmias in both hu-
mans and rats (14,15,33,34) and that, at least in rats, the
long-term use of an angiotensin-converting enzyme inhibitor
serves to reverse many of these changes (8,14,15). A third
possible mechanism may he the result of the hemodynamic
and neurohumoral effects of captopril because high levels of
catecholamines and angiotensin 11 are known to facilitate the
development of ventricular arrhythmias (35-37), as does
increased myocellular stretch (36) . A fourth, and less likely,
important possibilit-, is a decrease in arrhythmias as a result
of a persistent increase in total body potassium due to the
potassium-sparing effects of captopril (38) . In essence, re-
gardless of the relative importance of each of these factors,
all of the changes caused by captopril are compatible with
our understanding of beneficial effects on induction of ven-
tricular arrhythmia.
Apart from decreasing systemic systolic arterial pressure
and heart rate, the use of propranolol did not significantly
alter the hemodynamic changes documented in saline-
treated rats with a large myocardial infarction. Evidence of
both left and right ventricular dysfunction persisted . Despite
this, the use of propranolol led to widespread changes in
neurohumoral activation. Propranolol therapy attenuated
the increase in plasma norepinephrine, possibly because of
its presynaptic effects (39), and totally prevented any in-
crease in plasma epinephrine . Also, it caused a significantly
greater increase in plasma aldosterone despite tending to
reduce plasma renin activity. This combination of hemody-
namic and neurohumoral changes was accompanied by
widespread changes in ventricular remodeling that were
JACC Voi. 23, No . 2
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generally opposite to those caused by captopril therapy . In
rats with a moderate and large myocardial infarction, the use
of propranolol led to greater ventricular dilation, to a trend
toward more scar thinning and to a disproportionate increase
in left ventricular cavity/mass ratio (dilation index), similar
to the findings by Fishbein et al . (9) . In addition, in our
study, we found that propranolol caused a mayked increase
in fibrosis of the remaining viable portion of the heart of rats
with either a moderate or a large infarction . These changes in
ventricular remodeling with propranolol were thus marked
and very different from those of captopril .
Why the use of propranolol led to a decrease in ventric-
ular arrhythmia inducibility despite causing markedly differ-
ent changes in ventricular remodeling from those caused by
captopril is uncertain and challenges conventional wisdom .
Propranolol therapy has been found to be particularly useful
in decreasing the incidence of sudden death in patients with
a large myocardial infarction (7) . Generally, the antiarrhyth-
mic effects of beta-blockers have been thought to be largely
the result of their direct myocardial and beta-blocking effects
(40). However, in our study, propranolol therapy was
stopped 48 h before the electrophysiologic study, a period of
time that should have, if anything, led to an exaggerated
response to beta-agonists as a result of receptor upregulation
(19) . Also, no decrease in heart rate at the time of electro-
physiologic testing was noted in this group . Thus, it would
appear that in this study, the antiarrhythmic effects of
propranolol were due to other important factors . On the
surface, propranolol modified ventricular remodeling in a
way that was diametrically opposed to that of captopril and
to what is generally thought to reduce the risk of ventricular
arrhythmias (11) . However, as well illustrated by Fishbein et
al . (9), propranolol therapy attenuates the development of
myocyte hypertrophy after infarction, hypertrophy perhaps
being a proarrhythmic element previously underestimated in
this model (11,14,15). Also, by increasing fibrosis in the
viable portions of the heart, propranolol may have reduced
the inhomogeneity in fibrosis between the peri-infarction
area and the rest of the heart, thereby paradoxically reducing
the risk of isolated regional slowing of conduction and
reentrant arrhythmias. Another possibility that was not
verified in this study is that long-term propranolol use led to
changes in sarcolemmal characteristics that reduce the risk
of arrhythmias . A final, unverified and unlikely possibility is
that propranolol therapy led to persistent beneficial hemo-
dynamic effects .
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